2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid

C68H78ClF2N15O12S2 — CID 166740094

IUPAC2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid
SMILESNCCCC[C@@H]1NC(=O)CCSCc2cccc(c2)CSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2cccc(Cl)c2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccc(F)cc23)NC(=O)[C@H](Cc2c[nH]c3ccc(F)cc23)NC(=O)CNC1=O
InChIInChI=1S/C68H78ClF2N15O12S2/c69-42-9-4-6-37(21-42)22-55-68(98)86-18-5-11-57(86)67(97)85-56(61(73)91)35-100-34-39-8-3-7-38(20-39)33-99-19-16-58(87)79-50(10-1-2-17-72)62(92)77-32-59(88)80-51(23-40-29-75-48-14-12-43(70)25-46(40)48)63(93)81-52(24-41-30-76-49-15-13-44(71)26-47(41)49)64(94)83-54(28-60(89)90)66(96)82-53(65(95)84-55)27-45-31-74-36-78-45/h3-4,6-9,12-15,20-21,25-26,29-31,36,50-57,75-76H,1-2,5,10-11,16-19,22-24,27-28,32-35,72H2,(H2,73,91)(H,74,78)(H,77,92)(H,79,87)(H,80,88)(H,81,93)(H,82,96)(H,83,94)(H,84,95)(H,85,97)(H,89,90)/t50-,51-,52-,53-,54-,55-,56-,57-/m0/s1
InChIKeyQYCSRWZSVQNKSQ-VHQHBSIPSA-N
MW1435.05 g/mol
LogP2.73
Rot. Bonds15

About 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid

2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid (PubChem CID 166740094) has the molecular formula C68H78ClF2N15O12S2 and a molecular weight of 1435.05 g/mol. Its IUPAC name is 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid.

Molecular Properties

Compound Name2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid
PubChem CID166740094
Molecular FormulaC68H78ClF2N15O12S2
Molecular Weight1435.05 g/mol
Exact Mass1433.51
IUPAC Name2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid
SMILESNCCCC[C@@H]1NC(=O)CCSCc2cccc(c2)CSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2cccc(Cl)c2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccc(F)cc23)NC(=O)[C@H](Cc2c[nH]c3ccc(F)cc23)NC(=O)CNC1=O
InChIInChI=1S/C68H78ClF2N15O12S2/c69-42-9-4-6-37(21-42)22-55-68(98)86-18-5-11-57(86)67(97)85-56(61(73)91)35-100-34-39-8-3-7-38(20-39)33-99-19-16-58(87)79-50(10-1-2-17-72)62(92)77-32-59(88)80-51(23-40-29-75-48-14-12-43(70)25-46(40)48)63(93)81-52(24-41-30-76-49-15-13-44(71)26-47(41)49)64(94)83-54(28-60(89)90)66(96)82-53(65(95)84-55)27-45-31-74-36-78-45/h3-4,6-9,12-15,20-21,25-26,29-31,36,50-57,75-76H,1-2,5,10-11,16-19,22-24,27-28,32-35,72H2,(H2,73,91)(H,74,78)(H,77,92)(H,79,87)(H,80,88)(H,81,93)(H,82,96)(H,83,94)(H,84,95)(H,85,97)(H,89,90)/t50-,51-,52-,53-,54-,55-,56-,57-/m0/s1
InChIKeyQYCSRWZSVQNKSQ-VHQHBSIPSA-N
XLogP2.73
TPSA419.78 Ų
H-Bond Donors14
H-Bond Acceptors15
Rotatable Bonds15
Heavy Atoms100
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001435.05
LogP ≤ 52.73
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
The IUPAC name of 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid (CID 166740094) is 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid.
What is the SMILES notation for 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
The canonical SMILES for 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid is NCCCC[C@@H]1NC(=O)CCSCc2cccc(c2)CSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2cccc(Cl)c2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccc(F)cc23)NC(=O)[C@H](Cc2c[nH]c3ccc(F)cc23)NC(=O)CNC1=O.
What is the InChIKey of 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
The InChIKey is QYCSRWZSVQNKSQ-VHQHBSIPSA-N. The full InChI is InChI=1S/C68H78ClF2N15O12S2/c69-42-9-4-6-37(21-42)22-55-68(98)86-18-5-11-57(86)67(97)85-56(61(73)91)35-100-34-39-8-3-7-38(20-39)33-99-19-16-58(87)79-50(10-1-2-17-72)62(92)77-32-59(88)80-51(23-40-29-75-48-14-12-43(70)25-46(40)48)63(93)81-52(24-41-30-76-49-15-13-44(71)26-47(41)49)64(94)83-54(28-60(89)90)66(96)82-53(65(95)84-55)27-45-31-74-36-78-45/h3-4,6-9,12-15,20-21,25-26,29-31,36,50-57,75-76H,1-2,5,10-11,16-19,22-24,27-28,32-35,72H2,(H2,73,91)(H,74,78)(H,77,92)(H,79,87)(H,80,88)(H,81,93)(H,82,96)(H,83,94)(H,84,95)(H,85,97)(H,89,90)/t50-,51-,52-,53-,54-,55-,56-,57-/m0/s1.
What are the key properties of 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid has a molecular weight of 1435.05 g/mol, XLogP of 2.73, 15 rotatable bonds, 14 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-14-[(3-chlorophenyl)methyl]-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid is sourced from PubChem (CID 166740094), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).